Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
Published: November 17th 2023 | Updated: June 12th 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: June 9th 2025 | Updated: June 12th 2025
Barzolvolimab Demonstrates Rapid Symptom Reduction in Chronic Spontaneous Urticaria
Published: June 7th 2025 | Updated: June 12th 2025
Late-Breaking Data: Lebrikizumab Demonstrates Efficacy in Patients With Skin of Color With AD
Published: November 9th 2023 | Updated: June 12th 2025
Evaluating Stress Levels in AD Treatment Plans
Published: June 7th 2025 | Updated: June 12th 2025
Dupilumab Significantly Enhances Quality of Life and Reduces Cumulative Impairment in Patients with Moderate to Severe Atopic Dermatitis